These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7813508)

  • 1. Urinary tract infection caused by quinolone-resistant Campylobacter coli.
    Pascual A; Martínez-Martínez L; García-Gestoso ML; Romero J
    Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):690-1. PubMed ID: 7813508
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
    García-Rodríguez JA
    Chemotherapy; 1998 Sep; 44 Suppl 1():28-30. PubMed ID: 9797421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea.
    Lagler H; Kiesewetter B; Raderer M
    BMC Infect Dis; 2016 Aug; 16():409. PubMed ID: 27519265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.
    Lemaire X; Dehecq C; Cattoen C; Garnier LD; Bournet BS; Yazdanpanah Y; Senneville E
    Ann Clin Microbiol Antimicrob; 2010 Feb; 9():8. PubMed ID: 20132561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter coli meningitis in a 57-year-old patient.
    Cambier A; Martiny D; Hallin M; Wautier M; Giot JB; Khaldi MZ; Cambier J; Léonard P
    Acta Clin Belg; 2018 Dec; 73(6):427-430. PubMed ID: 29384014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.
    Engberg J; Neimann J; Nielsen EM; Aerestrup FM; Fussing V
    Emerg Infect Dis; 2004 Jun; 10(6):1056-63. PubMed ID: 15207057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of urinary tract infection with cefixime].
    Fujisawa M; Sasaki M; Fujii H; Okamura K; Miyata M; Hashimoto H; Yachiku S; Yamauchi K; Yamaguchi S; Inagaki N
    Hinyokika Kiyo; 1989 Nov; 35(11):1989-92. PubMed ID: 2694832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
    François P; Croizé J; Bost C; Wollschlager K
    Arch Pediatr; 1995 Feb; 2(2):136-42. PubMed ID: 7735445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
    McCarthy M; Aarons D; Scott HV
    N Z Med J; 1990 Mar; 103(885):106. PubMed ID: 2314731
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
    Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
    S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children.
    Dagan R; Einhorn M; Lang R; Pomeranz A; Wolach B; Miron D; Raz R; Weinstock A; Steinberger J
    Pediatr Infect Dis J; 1992 Mar; 11(3):198-203. PubMed ID: 1565534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study].
    Modai J
    Presse Med; 1989 Oct; 18(32):1614-6. PubMed ID: 2530545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of Campylobacter infections].
    Gracheva NM; Partin OS; Shcherbakov IT; Ivanova VI; Fokin SN
    Antibiot Khimioter; 1992 Jun; 37(6):31-5. PubMed ID: 1417342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient.
    Tokuda K; Nishi J; Miyanohara H; Sarantuya J; Iwashita M; Kamenosono A; Hizukuri K; Wakimoto N; Yoshinaga M
    Pediatr Infect Dis J; 2004 Jun; 23(6):577-9. PubMed ID: 15194845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of pediatric infections with cefixime].
    Helwig H
    Infection; 1990; 18 Suppl 3():S147-9. PubMed ID: 2079376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity and clinical evaluation of cefixime in urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 1998 Apr; 81(4):301-4. PubMed ID: 9623027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and antimicrobial behavior of Campylobacter jejuni and Campylobacter coli in children with diarrhea in Loja city, Ecuador].
    Simaluiza R; Toledo Z; Fernández H
    Rev Chilena Infectol; 2018 Apr; 35(2):213-215. PubMed ID: 29912263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production.
    Pérez-Boto D; García-Peña FJ; Abad-Moreno JC; Echeita MA
    Microb Drug Resist; 2013 Aug; 19(4):323-30. PubMed ID: 23391315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin.
    Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Jiminez EM; Malik GM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():247-52. PubMed ID: 6296015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.